register

Digital & Innovation

CSIRO discussion paper on the ethics of AI

Health Industry Hub | April 16, 2019 |

Artificial Intelligence (AI) has the potential to provide social, economic, and environmental benefits. For Australia to realise these benefits, it’s important for citizens to have trust in how AI is being designed, developed and used by business and government.

The CSIRO are seeking your views on a discussion paper to inform the Government’s approach to AI ethics in Australia. The discussion paper was developed by CSIRO’s Data61 and designed to encourage conversations about AI ethics in Australia.

The paper and your feedback will help the CSIRO ensure AI is developed and applied responsibly in Australia.

The Ethics Framework research was funded by the government in the 2018 May Budget. The work was guided by a steering committee of experts from industry, government and community organisations as well as researchers from CSIRO and Data61. Consultative workshops were also held in Sydney, Brisbane, Melbourne and Perth during 2018.


Digital & Innovation

Liverpool Hospital partners with Microsoft in cardiology care

Health Industry Hub | December 8, 2023 |

Digital & Innovation: Liverpool Hospital and tech giant Microsoft have joined forces in a collaboration aimed at enhancing the way […]

More


News & Trends - MedTech & Diagnostics

Sydney cancer centre welcomes new medical technology ahead of grand opening

Sydney cancer centre welcomes new medical technology ahead of grand opening

Health Industry Hub | December 8, 2023 |

MedTech & Diagnostics News: A $52 million integrated cancer treatment facility in Campbelltown, located in south-western Sydney, is swiftly advancing […]

More


News & Trends - Pharmaceuticals

Largest pharmacy retailer ASX debut via wholesaler takeover sparks industry concerns - Chemist Warehouse, Sigma Healthcare

Largest pharmacy retailer ASX debut via wholesaler takeover sparks industry concerns

Health Industry Hub | December 8, 2023 |

Pharma News: Australia’s largest pharmacy retailer is gearing up for a significant move as it eyes a listing on the […]

More


News & Trends - Pharmaceuticals

Eli Lilly's rheumatoid arthritis medicine to slow progression of type 1 diabetes, say Aussie researchers

Eli Lilly’s rheumatoid arthritis medicine to slow progression of type 1 diabetes, say Aussie researchers

Health Industry Hub | December 8, 2023 |

Pharma News: Australian researchers have shown that a commonly prescribed rheumatoid arthritis medicine can stop the progression of type 1 […]

More


This content is copyright protected. Please subscribe to gain access.